← back to search

Minghui Zhao

Yale Cancer Center · US
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Anemia and Osimertinib, with related work in GATA6, End-stage kidney disease, Salvia miltiorrhiza. Notable publications include 'Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis', 'Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs', and 'Control of Alveolar Differentiation by the Lineage Transcription Factors GATA6 and HOPX Inhibits Lung Adenocarcinoma Metastasis'.
h-index
citations
1,138
works
10
NIH funding
primary concept
email

Recent publications

Therapeutic potential of targeting the NEDD4L-eEF1A1 axis in cancer therapy
Acta Biochimica et Biophysica Sinica 2025cited by 2position: middledoi
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy
Kidney International Reports 2024cited by 22position: lastdoi
Trends and the Role of Gene-Environment Interactions in Idiopathic Membranous Nephropathy in Northern China
American Journal of Nephrology 2024cited by 2position: lastdoi
Cancer Cells Enter an Adaptive Persistence to Survive Radiotherapy and Repopulate Tumor
Advanced Science 2023cited by 28position: middledoi
The Function of Spag6 to Repair Brain Edema Damage After Cerebral Ischemic Stroke-reperfusion
Neuroscience 2023cited by 4position: middledoi
Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy
Kidney International 2022cited by 17position: lastdoi
Predictors of Kidney Outcomes of Anti-Glomerular Basement Membrane Disease in a Large Chinese Cohort
American Journal of Nephrology 2022cited by 15position: lastdoi
Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
Clinical Cancer Research 2020cited by 228position: middledoi
Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world
Kidney International Supplements 2020cited by 59position: middledoi
Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis
Cancer Cell International 2020cited by 33position: middledoi
A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China
American Journal of Nephrology 2020cited by 29position: lastdoi
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
New England Journal of Medicine 2019cited by 608position: middledoi
Incidence and Risk Factors of in-hospital mortality from AKI after non-cardiovascular operation: A nationwide Survey in China
Scientific Reports 2017cited by 15position: middledoi
Control of Alveolar Differentiation by the Lineage Transcription Factors GATA6 and HOPX Inhibits Lung Adenocarcinoma Metastasis
Cancer Cell 2013cited by 141position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zhao Cui · King University2 papers (2022–2022)Suxia Wang · Peking University2 papers (2020–2024)Li Zuo · King University1 papers (2019–2019) · 1 papers (2023–2023)Richard J. Glassock · University of Southern California1 papers (2020–2020)Zhiyu Ni · Hebei University of Engineering1 papers (2025–2025)Juan Tao · Palo Alto University1 papers (2020–2020)Hao Li · Anhui Medical University1 papers (2019–2019)Yujing Zhang · Fujian Medical University1 papers (2024–2024)Bing Liu · Central South University1 papers (2024–2024)Lei Liu · Suizhou Central Hospital1 papers (2022–2022)Xiaodan Zhang · Zhengzhou University1 papers (2022–2022)Zhihong Liu · Czech Academy of Sciences, Institute of Plasma Physics1 papers (2019–2019)Yiwei Wang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2023–2023)Xuemei Li · Chongqing University1 papers (2019–2019)Tingting Wang · Ningbo University1 papers (2025–2025)Ling Zhang · First Affiliated Hospital of Guangzhou Medical University1 papers (2023–2023)Hui Wang · People’s Hospital of Rizhao1 papers (2020–2020)Changying Xing · Nanjing Medical University1 papers (2019–2019)Ying Li · Jiangsu University1 papers (2024–2024)